125 related articles for article (PubMed ID: 9743908)
1. [Efficacy and safety of intramuscular imipenem/cilastatin (IPM/CS) for complicated urinary tract infections].
Shindo K; Hori T; Hayashi M; Kiyokawa S; Maeda K; Iwasaki S; Maruta N; Yamada J; Morimitsu H; Taide M; Hoshino K; Shimomae H; Matsuo R; Suzu H; Nishimura N; Hashiguchi J; Saito Y
Jpn J Antibiot; 1997 Jul; 50(7):628-39. PubMed ID: 9743908
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of sodium imipenem/cilastatin on patients of complicated urinary tract infections--following the failure of prior antimicrobial agents].
Yoshida K; Kobayashi N; Tohsaka A; Uchijima Y; Takeuchi S; Saitoh H; Negishi T; Yamada T; Nagamatsu H; Masuda H
Hinyokika Kiyo; 1992 Apr; 38(4):495-9. PubMed ID: 1529826
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Iwai N; Nakamura H; Miyazu M; Kasai K; Taneda Y
Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858
[TBL] [Abstract][Full Text] [Related]
4. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
Portsmouth S; van Veenhuyzen D; Echols R; Machida M; Ferreira JCA; Ariyasu M; Tenke P; Nagata TD
Lancet Infect Dis; 2018 Dec; 18(12):1319-1328. PubMed ID: 30509675
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
Sims M; Mariyanovski V; McLeroth P; Akers W; Lee YC; Brown ML; Du J; Pedley A; Kartsonis NA; Paschke A
J Antimicrob Chemother; 2017 Sep; 72(9):2616-2626. PubMed ID: 28575389
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
Sawae Y; Niho Y; Okamura T; Gondo H; Kozuru M; Uike N; Muta K; Goto T; Suehiro Y; Kumakawa M; Nishimura J; Yufu Y; Ishikura H; Yamashita S; Hisano S; Morioka E; Nakajima H; Shibuya T; Yamasaki K; Harada N; Asayama R; Hayashi S; Akashi K; Suematsu E; Kawasaki C
Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Hashira S; Tajima T; Fujii R
Jpn J Antibiot; 1989 May; 42(5):1077-86. PubMed ID: 2746857
[TBL] [Abstract][Full Text] [Related]
8. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
Takamoto M; Ishibashi T; Toyoshima H; Tanaka H; Tamaru N; Watanabe K; Yoshida M; Tokunaga N; Ichikawa Y; Oizumi K
Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Vazquez JA; González Patzán LD; Stricklin D; Duttaroy DD; Kreidly Z; Lipka J; Sable C
Curr Med Res Opin; 2012 Dec; 28(12):1921-31. PubMed ID: 23145859
[TBL] [Abstract][Full Text] [Related]
10. [Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Fukabori T; Mizobuchi K; Nakamura M; Takizawa H; Takashina R; Fujita Y
Jpn J Antibiot; 1997 Apr; 50(4):299-305. PubMed ID: 9192247
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J
Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H
Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Konaga E; Takeuchi H; Orita K; Fuchimoto S; Ogawa K; Kitagawa T; Tokuda N; Kimura H; Hamada F; Nishiyama Y
Jpn J Antibiot; 1991 Dec; 44(12):1341-50. PubMed ID: 1798068
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Chimura T; Banzai M; Yamazaki K; Miyata R; Yokoyama Y; Matsuo M; Oda T; Kihara K; Kanasugi H; Takahashi H
Jpn J Antibiot; 1991 Dec; 44(12):1351-8. PubMed ID: 1798069
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients].
Yamamoto M; Ina Y; Takada K; Noda M; Morishita M; Senda Y; Torii Y; Kakihara H; Yoshikawa K; Sugiura T
Jpn J Antibiot; 1991 Apr; 44(4):388-97. PubMed ID: 1652653
[TBL] [Abstract][Full Text] [Related]
16. [Bacteriological and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Sunakawa K; Ishizuka Y; Saito N; Akita H; Iwata S; Sato Y; Oikawa T
Jpn J Antibiot; 1988 Nov; 41(11):1692-703. PubMed ID: 3062204
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
18. [Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
Sawada H; Sasada M; Tajima M; Yamamoto K; Yasuda N; Omori S; Yumoto Y; Ishibashi T; Okada H; Suzuki T
Jpn J Antibiot; 1995 Feb; 48(2):271-7. PubMed ID: 7538179
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of imipenem/cilastatin sodium for respiratory infections in patients with lung cancer].
Yoshida M; Watanabe K; Tanaka H; Senju S; Ishibashi T; Takamoto M; Oizumi K; Kondo Y; Shigematsu H; Ohno T; Ichikawa Y; Hara N; Mitsuyama T; Nakanishi Y; Yamada H; Kuroki S; Motohiro A; Ueda H; Kusano T; Hiratsuka M; Nikaido Y; Kido M; Miyahara T; Ninomiya K; Naoe H
Jpn J Antibiot; 1997 Jan; 50(1):22-38. PubMed ID: 9059911
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies of efficacy of imipenem/cilastatin sodium against urinary tract infections with ureterocutaneostomy].
Yogi S; Yoshikawa H; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1992 Mar; 38(3):373-7. PubMed ID: 1523997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
